Abstract Protein synthesis is suppressed in working skeletal muscle. Teleologically, the skeletal muscle halts an ATP-consuming anabolic process such as protein synthesis to spare ATP for contractile activity during an emergency. So far, 2 mechanisms have been proposed for halting protein synthesis in working muscle. One of these mechanisms suggests that AMPK inhibits mTORC1, which is arguably a master regulator of the initiation step in protein translation. Another theory suggests Ca 2+ -dependent inactivation of eukaryotic elongation factor 2 (eEF2), which regulates the elongation step in protein translation. Previous reports in the literature suggest that factors other than AMPK and/or eEF2 are involved in the suppression of protein synthesis. We have recently shown that REDD1 might also be involved in blunting protein synthesis in working muscle. Understanding these mechanisms might lead to the development of new strategies and treatments, not only for athletes but also for individuals with musclewasting conditions such as sarcopenia.
Skeletal muscle is a highly plastic tissue that has the ability to alter the amount and composition of its subcellular components (such as contractile machinery, mitochondria, and glycolytic enzyme levels) in response to a variety of chronic perturbations including, but not limited to, altered states of neural activity, mechanical stress, physiological activity, and hormonal manipulation 1) . These adaptive processes in the skeletal muscle should be accompanied by dynamic protein turnover (i.e., required components are newly synthesized and others are degraded). It is now well recognized that protein synthesis is suppressed during exercise regardless of the exercise type (e.g., resistance exercise or non-resistance exercise such as endurance exercise), and muscle protein synthesis is upregulated afterwards, during recovery from exercise. However, the mechanisms by which muscle protein synthesis is suppressed during exercise and increased following exercise are poorly understood. This review briefly describes the possible molecular mechanisms involved in the suppression of protein synthesis in working muscle.
Both muscle contraction and protein synthesis involve ATP utilization. Therefore, teleologically, muscle metabolic machinery has higher priority to use ATP for muscle contraction than for maintenance during exercise. This concept was first proposed by Bylund-Fellenius et al. 2) about 30 years ago. Using perfused rat hindlimb, they demonstrated that contractile activity was associated with a marked decrease in muscle protein synthesis and that the effect appeared to be associated with a reduced ATP/ ADP ratio. A mechanistic link between lower energy status and suppression of muscle protein synthesis in working skeletal muscle has been defined by Bolster et al. 3) who found that AMP-activated protein kinase (AMPK), which is a cellular energy gauge, downregulates the mammalian target of rapamycin complex 1 (mTORC1). mTORC1 serves as a convergence point for signaling by growth factors, amino acids, and exercise to the mRNA binding step of translation initiation through phosphorylation of eukaryotic initiation factor (eIF) 4E binding protein 1 (4E-BP1) and/or the ribosomal protein S6 kinase 1 (S6K1) 4) . AMPK directly phosphorylates and inactivates mTOR, which constitutes a core of the complex. In addition, AMPK phosphorylates and stimulates the activity of tuberous sclerosis complex (TSC) 2, which is one of the upstream repressors of mTORC1 signaling 5) . Many lines of evidence support the theory that activation of AMPK by exercise-induced increases in AMP/ATP and/or reduced glycogen content results in targeted deactivation of mTORC1, which in turn decreases phosphorylation of 4E-BP1 and S6K1 that is necessary for the initiation of protein synthesis in the skeletal muscle of humans 6) and rodents 7) . On the other hand, Rose et al. 8) proposed that Ca 2+ -calmodulin-eukaryotic elongation factor 2 (eEF2) kinaseeEF2 signaling cascade might be more important for suppressing muscle protein synthesis than the AMPKmTORC1 pathway. The activity of eEF2, which regulates the elongation step in protein translation, is regulated by Correspondence: tamuraka@sgk.ac.jp Taro Murakami reversible phosphorylation. This phosphorylation inhibits eEF2 activity by preventing eEF2 from binding to the ribosome, and thereby decreasing the elongation rate. Rose et al. 8) demonstrated the following: (1) Contraction of rodent skeletal muscle suppressed protein synthesis (approximately 70%), and this finding correlated more closely with changes in eEF2 than in 4E-BP1 phosphorylation.
(2) Incubation of the muscle in Ca 2+ releasing agents suppressed muscle protein synthesis to the same extent as that observed by contraction. Also, the Ca 2+ -dependent decrease in protein synthesis was suppressed up to 50% by inhibiting energy turnover using ATPase inhibitors. (3) eEF2 kinase inhibition completely suppressed increases in eEF2 phosphorylation, whereas the suppression of protein synthesis was partly restored (30~40%) during contraction. These results suggest that the suppression of muscle protein synthesis by contraction is not merely a consequence of deactivation of peptide elongation by eEF2. (4) The suppression of protein synthesis by contraction in the AMPK kinase-dead muscle was not different from that observed in the wild-type muscle. Moreover, the profiles of inhibitory 4E-BP1 and eEF2 phosphorylation in kinase-dead muscle were identical to those in wildtype muscle. These data clearly demonstrate that AMPK activity is not necessary for the suppression of mTORC1 signaling or stimulatory eEF2 phosphorylation, but that other negative influences upon eEF2 and/or 4EBP1 are involved.
Regulated in development and DNA damage response 1 (REDD1) was originally identified as a gene that is transcriptionally upregulated in response to hypoxia 9) and subsequently shown to act as an upstream suppressor of mTORC1 signaling 10) . Diverse conditions (e.g., ATP depletion, DNA damage, endoplasmic reticulum stress, hypoxia, glucocorticoid) transcriptionally induce REDD1 expression and inhibit mTORC1 signaling by releasing TSC2 from its inhibitory 14-3-3 partners 10) . Because the above factors to induce REDD1 expression usually appear under conditions of exercise, we hypothesized that a putative increase in skeletal muscle REDD1 expression might be a part of a molecular mechanism by which mTORC1 activity, and thus protein synthesis, is decreased during exercise 11) . In addition, we determined whether ingestion of glucose or branched-chain amino acids (BCAAs) before exercise alters the expression of REDD1 in muscle 11) . We observed that endurance exercise repressed the mTORC1-signaling pathway regardless of ingestion of nutrients before the exercise in rat gastrocnemius muscle, as shown by dephosphorylation of 4E-BP1. In addition, exercise induced the expression of REDD1 mRNA (up to 8-fold) and protein (up to 3-fold). Exerciseinduced expression of REDD1 was not affected by the ingestion of glucose or BCAA. Therefore, we now think that enhanced expression of REDD1 may be an important mechanism that could partially explain the downregulation of mTORC1 signaling and the subsequent inhibition of protein synthesis in skeletal muscle during exercise.
It is generally accepted that protein synthesis is suppressed in working skeletal muscle. The mechanisms by which contracting muscle suppresses protein synthesis involves at least signaling of AMPK, eEF2 and/or REDD1 (Fig. 1) . A better understanding of the switching mechanisms by which muscle controls protein synthesis from down-to upregulation during the postexercise period will allow the development of new strategies and treatments, not only for athletes but also for individuals with musclewasting conditions such as sarcopenia. 
